A Single-center prospective pilot study enrolling chest pain patients. CD 26 measurement will be performed and compared to troponin µs for early triage of these patients. This novel biomarker of myocardial ischemia (CD26) will be measured at the time of first medical contact (T0) and after 30 min simultaneously o troponin Ic. All patients aged over 18 years with chest pain which may be related to acute coronary syndrome requiring pre hospital medical contact through the Emergency Medical Service.
First objectives: demonstrating the early positivity of CD26 compared to ultra-sensitive troponin.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
100
Assistance Publique Hopitaux de Marseille
Marseille, France
blood sample : dosage of CD26
demonstrating the early positivity of CD26 compared to ultra-sensitive troponin.
Time frame: 12 MONTHS
blood sample: dosage of the copeptin
Time frame: 12 months
blood sample: dosage of troponin
Time frame: 12 months
blood sample : dosage of IMA
IMA (Albumin modified by the ischaemia)
Time frame: 12 months
blood sample: dosage of adenosin
Time frame: 12months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.